FDA Approves Bristol Myers Blood Cancer Drug
The US FDA approved Bristol Myers Squibb's Zenbexus for a rare form of relapsed blood cancer. The oral drug is given with other therapies and carries a boxed warning.
X24 PerspectiveRelated Assets:
X24 Perspective